Nutex Health Inc.
NUTXHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeNutex Health Inc. operates as a healthcare services and operations company in the United States. The company carries a $1.32B market cap, placing it firmly in the small-cap category. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate.
Market Cap
$1.32B
Beta
2.02
P/E (TTM)
7.49
P/E (Fwd)
9.51
EPS (TTM)
$25.81
EPS (Fwd)
$20.33
ROE
64.6%
ROA
33.3%
Cash
$205.2M
Total Debt
$347.3M
Free CF
$130.7M
52W Change
131.7%
Annual Financials
Cash vs Debt
Where NUTX stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, NUTX finished 42.31% above its 150-day moving average ($134.92) and 36.93% above its 200-day moving average ($140.22). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NUTX overbought or oversold?
At the September 3, 2026 close, NUTX's RSI(14) was 57.8, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Nutex Health Inc. carries $347.3M in total debt against $205.2M in cash reserves — debt is roughly 1.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $130.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 64.6%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 33.3% further supports the picture of efficient asset utilization. Revenue has grown from $331.5M (2021) to $875.3M (2025), reflecting a 164% increase over the period.
A beta of 2.02 means NUTX is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. No single metric tells the full story. Reviewing NUTX's risk profile alongside its fundamentals and technical indicators provides a more complete picture.